The facility, called the Scottish Structural Proteomics Facility, features robotic equipment, cloning and expression technology, and Invitrogen's flagship Gateway technology. It will serve scientists from 14 research groups, including groups from
"The study of the structure of proteins is essential in the fight against drug resistant bacteria, viruses and parasites, which afflict many people in Scotland and the world," said James Naismith, a professor in chemistry and biomolecular sciences at the University of St. Andrews, who will be overseeing the SSPF projects along with Malcolm White, also of St. Andrews, and Bill Hunter of the University of Dundee.
The SSPF was originally funded by a development grant from the Scottish Higher Education Funding Council, a funding agency established by the
Projects that will be worked on at the SSPF include proteomics studies of methicillin resistant Staphylococcus aureus and the construction of a database of enzymes. The projects aim to identify new targets for antibiotic development and to elucidate how a variety of dangerous human viruses enter into cells and evade immune responses.